A 39-year-old woman, Natasha Whiting, describes being left “heartbroken” after three failed IVF attempts in May and says she spent more than £10,000 on additional IVF-related treatments in an effort to become pregnant. In reporting that draws attention to potential risks, she claims that she later learned the “add-on” therapies can negatively affect fertility and her ability to conceive. The accounts emphasize her personal experience and the cost of pursuing extra interventions after failed cycles. Across the two sources, her central narrative is the same: repeated IVF failure drives desperation to try further options, and she later expresses concern that many women may not understand possible downsides of add-on fertility treatments. The articles do not provide specific clinical details about which add-on treatments she used, what risks were identified, or how the information was determined. The coverage is primarily focused on her experience and warning rather than on broader medical evidence or a separate analysis of the overall safety and effectiveness of specific add-on IVF therapies.